Which closed-end funds own Ligand Pharmaceuticals Inc?
8 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $15.8M. Security type: debt security. Country: United States. CUSIP 53220KAG3 · ISIN US53220KAG31.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BCV Bancroft Fund | U.S. Equity | 2.32% | $4.5M | 2,600,000 par | $192M | 13.4% discount | Jun 30, 2026 |
| GCV Gabelli Convertible & Income Securities Fund | Convertible Securities | 2.20% | $2.1M | 1,250,000 par | $97.4M | 3.3% discount | Jun 30, 2026 |
| ECF Ellsworth Growth & Income Fund | U.S. Equity | 1.91% | $4.5M | 2,600,000 par | $233M | 11.7% discount | Jun 30, 2026 |
| NCZ Virtus Convertible & Income Fund II | Convertible Securities | 0.20% | $946K | 595,000 par | $463M | 7.3% discount | Jul 31, 2026 |
| NCV Virtus Convertible & Income Fund | Convertible Securities | 0.20% | $1.2M | 750,000 par | $601M | 9.6% discount | Jul 31, 2026 |
| ACV Virtus Diversified Income & Convertible Fund | Convertible Securities | 0.19% | $707K | 445,000 par | $380M | 4.9% discount | Jul 31, 2026 |
| NIE Virtus Equity & Convertible Income Fund | Convertible Securities | 0.12% | $946K | 595,000 par | $786M | 10.3% discount | Jul 31, 2026 |
| NFJ Virtus Dividend, Interest & Premium Strategy Fund | U.S. Equity | 0.06% | $946K | 595,000 par | $1.5B | 7.3% discount | Jul 31, 2026 |
8 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Ligand Pharmaceuticals I | debt security | 14 |
| Ligand Pharmaceuticals Inc | common equity | 1 |
Issuer-level search for “LIGAND PHARMACEUTICALS INC” → · Compare two funds’ portfolios →